Cargando…

Cardiosphere-Derived Cells Reverse Heart Failure With Preserved Ejection Fraction in Rats by Decreasing Fibrosis and Inflammation

The pathogenesis of heart failure with a preserved ejection fraction (HFpEF) is unclear. Myocardial fibrosis, inflammation, and cardiac hypertrophy have been suggested to contribute to the pathogenesis of HFpEF. Cardiosphere-derived cells (CDCs) are heart-derived cell products with antifibrotic and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gallet, Romain, de Couto, Geoffrey, Simsolo, Eli, Valle, Jackelyn, Sun, Baiming, Liu, Weixin, Tseliou, Eleni, Zile, Michael R., Marbán, Eduardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	PRE-CLINICAL RESEARCH
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834906/ https://www.ncbi.nlm.nih.gov/pubmed/27104217 http://dx.doi.org/10.1016/j.jacbts.2016.01.003

Ejemplares similares

Angiogenesis, Cardiomyocyte Proliferation and Anti-Fibrotic Effects Underlie Structural Preservation Post-Infarction by Intramyocardially-Injected Cardiospheres
por: Tseliou, Eleni, et al.
Publicado: (2014)

Durable Benefits of Cellular Postconditioning: Long‐Term Effects of Allogeneic Cardiosphere‐Derived Cells Infused After Reperfusion in Pigs with Acute Myocardial Infarction
por: Kanazawa, Hideaki, et al.
Publicado: (2016)

Follistatin-Like 1 Regulates Hypertrophy in Heart Failure With Preserved Ejection Fraction
por: Tanaka, Komei, et al.
Publicado: (2016)

Widespread Myocardial Delivery of Heart-Derived Stem Cells by Nonocclusive Triple-Vessel Intracoronary Infusion in Porcine Ischemic Cardiomyopathy: Superior Attenuation of Adverse Remodeling Documented by Magnetic Resonance Imaging and Histology
por: Tseliou, Eleni, et al.
Publicado: (2016)

Relative Roles of CD90 and c‐Kit to the Regenerative Efficacy of Cardiosphere‐Derived Cells in Humans and in a Mouse Model of Myocardial Infarction
por: Cheng, Ke, et al.
Publicado: (2014)

Allogeneic Cardiospheres Delivered via Percutaneous Transendocardial Injection Increase Viable Myocardium, Decrease Scar Size, and Attenuate Cardiac Dilatation in Porcine Ischemic Cardiomyopathy
por: Yee, Kristine, et al.
Publicado: (2014)

Reverse electrical remodeling in rats with heart failure and preserved ejection fraction
por: Cho, Jae Hyung, et al.
Publicado: (2023)

Mechanistic and therapeutic distinctions between cardiosphere-derived cell and mesenchymal stem cell extracellular vesicle non-coding RNA
por: Walravens, Ann-Sophie, et al.
Publicado: (2021)

Y RNA fragment in extracellular vesicles confers cardioprotection via modulation of IL‐10 expression and secretion
por: Cambier, Linda, et al.
Publicado: (2017)

Stimulation of endogenous cardioblasts by exogenous cell therapy after myocardial infarction
por: Malliaras, Konstantinos, et al.
Publicado: (2014)

Diffusion Tensor Cardiac Magnetic Resonance Reveals Exosomes From Cardiosphere-Derived Cells Preserve Myocardial Fiber Architecture After Myocardial Infarction
por: Nguyen, Christopher T., et al.
Publicado: (2018)

Diastolic Dysfunction With Preserved Ejection Fraction After the Fontan Procedure
por: Chowdhury, Shahryar M., et al.
Publicado: (2022)

Dose-dependent functional benefit of human cardiosphere transplantation in mice with acute myocardial infarction
por: Shen, Deliang, et al.
Publicado: (2012)

Enhancing retention and efficacy of cardiosphere-derived cells administered after myocardial infarction using a hyaluronan-gelatin hydrogel
por: Smith, Rachel Ruckdeschel, et al.
Publicado: (2013)

Therapeutic benefits of intravenous cardiosphere-derived cell therapy in rats with pulmonary hypertension
por: Middleton, Ryan C., et al.
Publicado: (2017)

Delayed repolarization and ventricular tachycardia in patients with heart failure and preserved ejection fraction
por: Cho, Jae Hyung, et al.
Publicado: (2021)

Magnetic antibody-linked nanomatchmakers for therapeutic cell targeting
por: Cheng, Ke, et al.
Publicado: (2014)

Seipin Knockout Mice Develop Heart Failure With Preserved Ejection Fraction
por: Bai, Bo, et al.
Publicado: (2019)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart
por: Malliaras, Konstantinos, et al.
Publicado: (2013)

Pragmatic Weight Management Program for Patients With Obesity and Heart Failure With Preserved Ejection Fraction
por: El Hajj, Elia C., et al.
Publicado: (2021)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Prognostic Value of Minimal Left Atrial Volume in Heart Failure With Preserved Ejection Fraction
por: Shin, Sung‐Hee, et al.
Publicado: (2021)

Biodistribution of unmodified cardiosphere‐derived cell extracellular vesicles using single RNA tracing
por: Ciullo, Alessandra, et al.
Publicado: (2022)

Validation of the Cardiosphere Method to Culture Cardiac Progenitor Cells from Myocardial Tissue
por: Davis, Darryl R., et al.
Publicado: (2009)

Left ventricular twist was decreased in isolated left bundle branch block with preserved ejection fraction
por: Yılmaz, Sabiye, et al.
Publicado: (2017)

Biomarkers in heart failure with preserved ejection fraction
por: Meijers, W. C., et al.
Publicado: (2016)

Management of heart failure with preserved ejection fraction
por: Gard, Emma, et al.
Publicado: (2020)

Managing heart failure with preserved ejection fraction
por: Davidson, Alexander, et al.
Publicado: (2020)

Biomarkers in Heart Failure with Preserved Ejection Fraction
por: Bayes-Genis, Antoni, et al.
Publicado: (2022)

Comorbidities in heart failure with preserved ejection fraction
por: Deichl, Andrea, et al.
Publicado: (2022)

Allogeneic cardiosphere-derived cells (CAP-1002) in critically ill COVID-19 patients: compassionate-use case series
por: Singh, Siddharth, et al.
Publicado: (2020)

Distinct features of calcium handling and β‐adrenergic sensitivity in heart failure with preserved versus reduced ejection fraction
por: Kilfoil, Peter J., et al.
Publicado: (2020)

Diabetes and pre‐diabetes in patients with heart failure and preserved ejection fraction
por: Jackson, Alice M., et al.
Publicado: (2022)

Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction
por: Shen, Li, et al.
Publicado: (2019)

Impact of diabetes on serum biomarkers in heart failure with preserved ejection fraction: insights from the TOPCAT trial
por: De Marco, Corrado, et al.
Publicado: (2021)

Metabolomic Fingerprint of Heart Failure with Preserved Ejection Fraction
por: Zordoky, Beshay N., et al.
Publicado: (2015)

Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction
por: Samson, Rohan, et al.
Publicado: (2016)

Animal models of heart failure with preserved ejection fraction
por: Conceição, G., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jeibuj3ufg590v5f4kd7b16io0